Seval Orman

6PUBLICATIONS
50CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Intensive care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 19, 2026
Outcomes of CDK4/6 Inhibitor-Based Therapy in Premenopausal HR+/HER2- Metastatic Breast Cancer: Real World Data From A Multicenter Study.

Hatice Odabaş, Omar Alomari, Seval Orman

|Feb 27, 2026
Association Between Body Mass Index and Clinical Outcomes of CDK4/6 Inhibitors in HR+/HER2- Metastatic Breast Cancer: A Real-World Cohort Study.

Seval Orman, Miray Aydoğan, Nisanur Sarıyar Busery

|Jan 28, 2026
Adjuvant Chemotherapy and Chemoradiotherapy in Gastric Cancer: Prognostic Determinants and Real-World Survival Outcomes.

Sedat Yildirim, Hatice Odabas, Seval Ay Ersoy

|Oct 29, 2025
The Effect of the Clinical-Pathological CPS+EG Staging System on Survival Outcomes in Patients with HER2-Positive Breast Cancer Receiving Neoadjuvant Treatment: A Retrospective Study.

Seval Orman, Miray Aydoğan, Oğuzcan Kınıkoğlu

|Mar 25, 2025
THE ROLE OF ULTRASONIC CARDIAC OUTPUT MONITOR IN EVALUATING STROKE VOLUME VARIATION TO DETERMINE FLUID RESPONSIVENESS IN PATIENTS WITH SHOCK.

Seval Orman, Pervin Hancı, Serdar Efe

|Jul 01, 2024
Efficacy of cumulative cisplatin dose on survival in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy: multicenter study by Turkish Oncology Group.

Arif Akyildiz, Melis Gultekin, Ecem Yigit

Pageof 1

Frequent Collaborators

4 joint publications

Hatice Odabaş

4 joint publications

Sedat Yıldırım

4 joint publications

Nedim Turan

3 joint publications

Deniz Işık